Clinical Trial

Prospective G7 Dual Mobility Total Hip PMCF

NCT: NCT03308929 · ACTIVE_NOT_RECRUITING

NCT IDNCT03308929

StatusACTIVE_NOT_RECRUITING

Start Date2017-02-28

Completion2029-02-28

SponsorZimmer Biomet (INDUSTRY)

First posted2017-10-13

Last updated2026-10-05

Brief Summary

This is a prospective multi-center clinical evaluation following recipients of the G7 Dual Mobility hip device. The primary objective is to characterize survivorship of the G7 hip at five years post-index procedure. Secondary objectives include documentation of clinical outcomes, safety and radiographic data.

Frequently Asked Questions

What is Prospective G7 Dual Mobility Total Hip PMCF?

Prospective G7 Dual Mobility Total Hip PMCF is a clinical trial registered under NCT03308929. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03308929?

The current status of NCT03308929 (Prospective G7 Dual Mobility Total Hip PMCF) is: ACTIVE_NOT_RECRUITING.

When did Prospective G7 Dual Mobility Total Hip PMCF start?

Prospective G7 Dual Mobility Total Hip PMCF started on 2017-02-28.

Related Devices

K243571Trabecular Metal Acetabular Revision System, Acetabular Liners and Constrained LinersZimmer Biomet K251620A.L.P.S. Proximal Humerus Plating SystemZimmer Biomet K261453G7® Acetabular SystemZimmer Biomet K190656Dual Mobility - Longevity and Vivacit-E Polyethylene Hip BearingsZimmer, Inc. K201657Corin Ltd. Hip Products: Trinity™ Acetabular System, Trinity™ PLUS Acetabular Shell, MetaFix™ Hip System, TriFit™ CF and TS Hip Systems, TaperFit™ Hip System, Revival™ Modular Hip System, MiniHip™, Trinity™ Dual Mobility, MobiliT, BiPolar-i, OMNI MOD™ Hip System, OMNI K1 and K2 Hip Systems, OMNI Bipolar Heads, Corin Biolox Delta Ceramic Heads, OMNI Delta Ceramic HeadsCorin, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.